Home/Filings/4/0001209191-11-024027
4//SEC Filing

Kennedy Robert Eugene 4

Accession 0001209191-11-024027

CIK 0001390478other

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 11:56 AM ET

Size

14.6 KB

Accession

0001209191-11-024027

Insider Transaction Report

Form 4
Period: 2011-04-13
Kennedy Robert Eugene
Vice President and CFO
Transactions
  • Award

    Common Stock

    2011-04-13+374,288374,288 total
  • Award

    Common Stock

    2011-04-13+2,430376,718 total(indirect: By Spouse)
  • Award

    Common Stock

    2011-04-13+2,576379,294 total(indirect: By LLC)
  • Award

    Stock Option

    2011-04-13+30,00030,000 total
    Exercise: $1.27Exp: 2021-04-12Common Stock (30,000 underlying)
Footnotes (7)
  • [F1]Received in exchange for 3,078,013 shares of Apthera, Inc. common stock in connection with merger of Apthers, Inc. into RXI Pharmaceuticals Corporation (the "Merger"). On the effective date of the Merger, the closing price of RXI Pharmaceuticals Corporation common stock was $1.275 per share.
  • [F2]Received in exchange for 20,000 shares of Apthera, Inc. common stock in connection with merger of Apthers, Inc. into RXI Pharmaceuticals Corporation (the "Merger"). On the effective date of the Merger, the closing price of RXI Pharmaceuticals Corporation common stock was $1.275 per share.
  • [F3]The reporting person is a managing member of the LLC that owns the reporting securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F4]Received in exchange for 21,200 shares of Apthera, Inc. common stock in connection with merger of Apthers, Inc. into RXI Pharmaceuticals Corporation (the "Merger"). On the effective date of the Merger, the closing price of RXI Pharmaceuticals Corporation common stock was $1.275 per share.
  • [F5]Granted pursuant to the RXi Pharmaceuticals Corporation 2007 Incentive Plan.
  • [F6]Per share.
  • [F7]1,250 of the options vested on July 13, 2011, with the remaining shares vesting in equal installments on each of the next 11 quarterly anniversaries of July 13, 2011.

Issuer

RXI PHARMACEUTICALS CORP

CIK 0001390478

Entity typeother

Related Parties

1
  • filerCIK 0001518512

Filing Metadata

Form type
4
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 11:56 AM ET
Size
14.6 KB